Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368641 · ClinicalTrials.gov registry record · Phase 2
Heart Failure and Peritoneal Ultrafiltration
A Phase 2 study, sponsored by Vantive Health.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00368641 is a Phase 2 study that was terminated before completion, run by Vantive Health. The registered enrollment target is 12 participants.
The verdict
NCT00368641, a Phase 2 study, was terminated before completion, sponsored by Vantive Health.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory quality of life in comparison to patients who remain on standard therapy alone.
Interventions
- DRUG Extraneal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00368641
The ClinicalTrials.gov registry entry for NCT00368641 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vantive Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Extraneal is the first listed.
NCT00368641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00368641 about?
NCT00368641 is a clinical study titled "Heart Failure and Peritoneal Ultrafiltration". The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory qua...
What is the current status of trial NCT00368641?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2006-08. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00368641?
The interventions under investigation include: Extraneal (DRUG).
Who is sponsoring clinical trial NCT00368641?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.